THAM is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Tromethamine.
Product ID | 0409-1593_f74e6c85-e528-45a1-8ce6-8381540626c6 |
NDC | 0409-1593 |
Product Type | Human Prescription Drug |
Proprietary Name | THAM |
Generic Name | Tromethamine |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2020-06-24 |
Marketing Category | NDA / NDA |
Application Number | NDA013025 |
Labeler Name | Hospira, Inc. |
Substance Name | TROMETHAMINE |
Active Ingredient Strength | 4 g/100mL |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-06-24 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA013025 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2020-03-24 |
Marketing End Date | 2017-06-01 |
Marketing Category | NDA |
Application Number | NDA013025 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2005-11-30 |
Marketing End Date | 2017-06-01 |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
THAM 88380252 not registered Live/Pending |
Milla Pharmaceuticals, Inc. 2019-04-10 |
THAM 72109309 0730621 Dead/Cancelled |
FISHER SCIENTIFIC COMPANY 1960-11-30 |